Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $51.4M
Accounts Receivable —
Inventory —
Total Current Assets $52.5M
Property, Plant & Equipment $2.0M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $54.5M
Liabilities
Accounts Payable $167.0K
Total Current Liabilities $4.1M
Long-Term Debt —
Total Liabilities $4.1M
Stockholders' Equity
Retained Earnings $-45.2M
Total Stockholders' Equity $-42.1M
← Newer Page 2 of 2 Older →